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239 ABSTRACT 
40 Epidemiologic evidence of an adverse association between exposure to methylmercury (MeHg) 
41 from consuming fish and heart rate variability (HRV) is inconclusive. We aimed to evaluate MeHg 
42 exposure in relation to HRV parameters in a large cohort of young adults from a high fish 
43 consuming population in the Republic of Seychelles. Main Cohort participants in the Seychelles 
44 Child Development Study were evaluated at a mean age of 19 years. Prenatal MeHg exposure 
45 was determined in maternal hair growing during pregnancy and recent exposure in participant’s 
46 hair taken at the evaluation.  The evaluation consisted of short (~2 hours) and long (overnight) 
47 Holter recordings obtained in 514 and 203 participants, respectively. Multivariable analyses 
48 examined the association of prenatal and recent MeHg exposure (in separate models) with time-
49 domain and frequency-domain HRV parameters in different physiologic circumstances: supine 
50 position, standing position, mental stress when undergoing a mathematics test, sleep, and long 
51 recording. Prenatal MeHg exposure was not associated with any of the 23 HRV parameters 
52 studied after adjustment for multiplicity. The recent MeHg showed a trend toward significance 
53 only for few variables in the primary model.  However, after additional adjustment for activity 
54 levels, polyunsaturated fatty acids, and multiplicity none were significant after a Bonferroni 
55 adjustment. In conclusion, prenatal and recent MeHg exposure had no consistent pattern of 
56 associations to support the hypothesis that they are adversely associated with heart rate 
57 variability in this study population that consumes large amounts of fish.
359 Fish is an important source of nutrition worldwide with about 3.1 billion people depending 
60 daily on fish as their primary source of protein (FAO 2016). However, all fish also contain naturally 
61 occurring methylmercury (MeHg) which is a known neurotoxicant in high dosages.  Maternal 
62 consumption during pregnancy of industrially polluted fish (after MeHg was discharged in waste 
63 water from a chemical plant and seed grain treated with a MeHg fungicide) have been associated 
64 with severe neurological deficits in children (WHO 2007).  Since neurotoxicity was observed after 
65 large exposure to MeHg, several studies have evaluated heart rate variability (HRV) to investigate 
66 the association between prenatal or recent MeHg exposure (Sorensen et al. 1999; Oka et al. 
67 2002; Grandjean et al. 2004; Murata et al. 2004; Choi et al. 2009; Lim, Chung, and Paek 2010).
68 Heart rate variability (HRV) is an accepted method to assess changes in the autonomic 
69 nervous system during parasympathetic and sympathetic modulation of the cardiovascular 
70 system (HRV 1996). Heart rate is under constant influence of an interplay between 
71 parasympathetic and sympathetic modulation leading to slower heart rate at rest or during sleep, 
72 and faster heart rate with exercise or stress. Beat-to-beat variation in heart rate, or in duration of 
73 beat-to-beat intervals, could be measured reflecting changes in the autonomic control of the heart 
74 (Kleiger, Stein, and Bigger 2005). In healthy subjects, it is expected that there is a physiologic 
75 variation of on NN intervals (defined as normal beats with sinus rhythm, while excluding premature 
76 and ectopic beats) influenced by respiration, baroreflex sensitivity, in addition to the above 
77 mentioned parasympathetic and sympathetic modulation (Cygankiewicz and Zareba 2013). HRV 
78 might be altered in patients after myocardial infarction, patients with heart failure, or those with 
79 diabetes, obesity, frequently with a decrease in parasympathetic modulation and an increased 
80 sympathetic modulation (HRV 1996; El Agaty, Kirmani, and Labban 2017; Tsuji et al. 1996). 
81 These changes in HRV have been found as predictors of outcome (mortality, heart failure, 
82 ventricular tachyarrhythmias) in various patient populations (Kleiger et al. 1987; Bigger et al. 1992; 
483 Stein et al. 1997; Kleiger, Stein, and Bigger 2005; Sherazi et al. 2015). There is profound evidence 
84 that in addition to environmental factors like exposure to air pollution or lead, pharmacological or 
85 electrical therapies might alter HRV parameters indicating changes in the autonomic control of 
86 the heart (Coumel et al. 1991; Malik et al. 1989; Simula et al. 2017; Jerling et al. 2018; 
87 Hoogerwaard et al. 2019; Petersen et al. 2018; Breitner et al. 2019; Gump et al. 2011). The 
88 guidelines regarding HRV analysis and its parameters recommended for research and clinical 
89 use were established in 1996 (HRV 1996). However, over the last 20 years there still have been 
90 inconsistencies regarding HRV methodology and interpretation (Shaffer and Ginsberg 2017).         
91 Some epidemiologic studies have suggested that MeHg exposure may be associated with 
92 a decrease in HRV parameters but with general inconsistency of findings among studies, 
93 (Grandjean et al. 2004; Mozaffarian 2009; Oka et al. 2002; Sorensen et al. 1999) and some were 
94 not able to confirm it (Valera, Dewailly, and Poirier 2008; Miller et al. 2018; Gump et al. 2017; 
95 Choi et al. 2009)  These studies have generally been based on short term HRV recordings at rest, 
96 and some were done in populations with co-exposures. Varying duration of recordings, diverse 
97 ECG sampling rate, different management of ectopic beats may influence results of HRV analyses 
98 (Shaffer and Ginsberg 2017; Karita et al. 2018; Stapelberg et al. 2018; Melo et al. 2018). These 
99 factors limit our understanding of whether there are systematic and direct cardiovascular effects 
100 of MeHg exposure (Karita et al. 2018). As recently summarized in two extensive reviews on the 
101 topic (Gribble et al. 2015; Karita et al. 2018) it is still uncertain whether MeHg exposure from 
102 repeated consumption of fish with naturally occurring background levels has any adverse and 
103 meaningful effect on HRV.  
104 In a prospective study of 19-year-old healthy subjects, we assessed whether the prenatal 
105 and recent MeHg exposure from consuming fish adversely affects HRV in comprehensive 
106 analyses of 24-hour Holter recordings and short-term 5-minute recordings reflecting different 
5107 physiologic conditions associated with resting supine, standing, mental stress (mathematics test), 
108 and sleeping.  
109
110 METHODS
111 Study Population and Design
112 The Republic of Seychelles is a 115-island archipelago in the middle of the Indian Ocean 
113 where citizens consume large amounts of ocean fish. The population is exposed to MeHg 
114 primarily from fish consumption and does not consume sea mammals (Cernichiari et al. 1995; 
115 Davidson et al. 1998).  Fish consumed in Seychelles are contaminated only by natural 
116 background exposure to MeHg.  This setting provides a unique opportunity to study the 
117 association of MeHg with health outcomes. In 1989-90,  779 mother-infant pairs were recruited 
118 as part of the Seychelles Child Development Study (SCDS) main cohort (Marsh et al. 1995).  The 
119 demographics and earlier evaluations of this cohort have been reported previously (Davidson et 
120 al. 1998; Shamlaye et al. 1995; Myers et al. 2003; van Wijngaarden et al. 2013). 
121 For this study, a total of 518 cohort participants returned for evaluations at the Study 
122 Centre at a mean ± SD of 19.0 ± 0.3 years of age. Data from four of these participants were not 
123 included due to technical errors in ECG data acquisition.  The evaluation consisted of a 
124 questionnaires collecting demographic, socioeconomic, medial history, and lifestyle data, 
125 collection of biological samples (hair and blood samples), and Holter ECG recordings providing 
126 time- and frequency-domain HRV parameters.  The study protocol was approved by the 
127 Institutional Review Boards of the Republic of Seychelles and the University of Rochester.
128 MeHg and Polyunsaturated Fatty Acids Measurements
6129 Prenatal MeHg exposure was determined by measurement of total maternal Hg levels in 
130 hair in samples collected closed to the scalp after pregnancy. It reflected mercury concentrations 
131 during pregnancy assuming a hair growth rate of 1 cm per month. Recent MeHg exposure was 
132 available for 451 (87.7%) of the participants; 68% of those missing this variable were males, many 
133 of whom had shaved heads. Recent MeHg  was analyzed in the 1 cm  hair samples collected 
134 closest to the scalp taken at the time of Holter testing (Myers et al. 2009).  Hair analysis was 
135 performed using cold vapor atomic absorption spectroscopy (Magos and Clarkson 1972). The 
136 detailed description of hair sampling, analysis and quality control procedures was previously 
137 described (Cernichiari et al. 1995). It has been documented that mercury hair levels recapitulate 
138 mercury exposure since hair concentrations correlate well with blood mercury levels (Clarkson, 
139 Magos, and Myers 2003). 
140 Recent status of n-3 and n-6 PUFA were determined from plasma samples taken at the 
141 time of evaluation.  Samples were processed, aliquoted, and stored at -80°C in the Ministry of 
142 Health’s Clinical Laboratories and transported to the nutrition biochemistry laboratory in 
143 Coleraine, Northern Ireland for fatty acid analysis.  Plasma samples were subjected to lipid 
144 extraction using an adaptation of the method of Folch et al. (Folch, Lees, and Sloane Stanley 
145 1957) and solid phase extraction columns (Merck Lichrolut, UK) were used to isolate 
146 phospholipids. Fatty acid methyl esters were prepared with boron trifluoride in methanol (Sigma-
147 Aldrich Co. Ltd.) and analyzed using GC-MS technology (5975C series, Agilent Technologies 
148 Ltd., Stockport, UK).  Fatty acids were identified by their retention time with reference to 
149 commercially obtained fatty acid standards and were quantified by use of an internal standard 
150 C17:0 (Sigma Aldrich Co. Ltd.). The GC column used was a BPX 70 capillary column 
151 (Phenomenex, Cheshire, UK) with a length of 100 m, internal diameter of 0.25 mm and a capillary 
152 thickness of 0.25 μm. 
7153 Holter ECG Recordings
154 All 514 participants underwent 12-lead high-resolution Holter ECG recordings which were 
155 initiated between 8-10 am using digital (1000 Hz) recorders (H-Scribe, Mortara Instruments Inc., 
156 Milwaukee, WI). ECG recordings started with a 10-minute supine position followed by a 10-minute 
157 standing and subsequently a 10-minute ECG while the participant was completing mathematics 
158 (math) test. The supine recording served to analyze HRV parameters in the resting non-active 
159 state (parasympathetic dominance), the standing recording provided insight into the response of 
160 the heart rate and HRV parameters to activation of the autonomic system by changing body 
161 position (sympathetic activation), and the recording during a mathematical test reflected the effect 
162 of mental stress on the studied ECG parameters (Tsuji et al. 1996; Umetani et al. 1998). The 
163 Holter recordings were finished after 1-2 hours in 312 subjects, but in the remaining 202 subjects 
164 recordings were continued to obtain long-term overnight data to further characterize the normal 
165 physiologic predominance of parasympathetic modulation of the autonomic nervous system 
166 during sleep and provide insight into the overall long-term values of time-domain HRV 
167 parameters.
168  All recordings were sent to and analyzed at the University of Rochester Medical Center’s 
169 ECG Core Laboratory by technicians blinded to participants’ demographic and methylmercury 
170 exposure data. Routine beat annotation was performed identifying normal sinus beats and 
171 abnormal beats (atrial and ventricular ectopic beats, noise) and only normal sinus beats were 
172 included in the analyses. In the case of ectopic beats, the sinus normal-to normal beat (NN) 
173 interval following the ectopic beat was not included. All recordings were verified by a cardiologist 
174 (WZ).
175
8176 Heart Rate Variability
177 From short-term recordings obtained in supine and standing positions and during the math 
178 test, 5-minute ECG recordings were extracted starting 3 minutes from the beginning of each 
179 segment to allow for adaptation to the changed conditions.  A 5-minute segment from the 
180 overnight Holter recording was also analyzed at approximately 2 am to represent HRV during 
181 sleep. 
182 Annotated NN intervals were used to compute HRV parameters for a given segment of 
183 data. The time-domain HRV parameters (Kleiger, Stein, and Bigger 2005) that were obtained from 
184 both the short (~5-minute) and long recordings included: SDNN (standard deviation of normal-to-
185 normal sinus beat intervals) reflecting overall HRV and rMSSD intervals (root mean square of 
186 successive differences in NN intervals). We also computed: pNN50 (percentage of NN intervals 
187 differing more than 50 ms from the preceding beat) reflecting parasympathetic modulation, 
188 SDANN (standard deviation of averaged 5-min normal-to-normal RR intervals), and SDNIX (mean 
189 of the SDs of all normal-to-normal RR intervals) for all 5-min segments of the entire recording 
190 (SDNNIX). These reflect overall HRV and are similar to SDNN, which is why we elected to focus 
191 on SDNN and rMSSD as representative HRV parameters in time-domain analysis. 
192 The frequency-domain HRV methods (Bigger et al. 1992) allow for identifying the relative 
193 contribution of specific frequency bands reflecting oscillatory behavior of the heart rate.  The total 
194 power (TP) of the entire spectrum was measured from 0 to 0.40 Hz. Other components included 
195 high frequency (HF: 0.15-0.40 Hz), low frequency (LF: 0.04-0.15 Hz), and very low frequency 
196 (VLF: 0.003-0.04 Hz) bands. The HF power (expressed in normalized units as HF/[TP-VLF]) 
197 represents parasympathetic (respiratory) modulation of the heart rate whereas LF power 
198 (expressed in normalized units as LF/[TP-VLF]) reflects modulation of the heart rate by both 
199 sympathetic and parasympathetic tones, but with strong dominance of sympathetic influence and 
9200 baroreflexes. We also evaluated LF/HF ratio but elected to focus on LF and HF separately to 
201 illustrate effects of MeHg on individual components of these variables. 
202 Our primary statistical analysis focused on 23 of the most commonly used HRV 
203 parameters reflecting autonomic activity in different physiologic conditions: 5 in supine position, 5 
204 in standing position, 5 in response to a mathematics test, 5 during sleep, and 3 for the entire 
205 recording. Five outcomes measured at baseline while supine at rest included: NN, SDNN, rMSSD, 
206 LF, and HF. We also analyzed the five outcomes measured at baseline minus their values while 
207 standing, taking a math test, and sleeping. Unless otherwise noted, response variables are 
208 defined as differences from baseline values. Three primary outcomes measured on the long 
209 recordings included: NN, SDNN, rMSSD.   Additionally, we computed three more HRV parameters 
210 (pNN50, SDANN, and SDNNIX) for secondary analysis by MeHg categories. 
211
212 Statistical Analyses
213 We used linear regression to examine the association of each exposure (prenatal and 
214 recent MeHg, in separate models) and each of the 23 HR variables.  Models first examined the 
215 association with a sex by exposure interaction term since significant differences in HRV are known 
216 to be present between males and females, and additionally, exposure differed by sex (Tsuji et al. 
217 1996; Umetani et al. 1998).  If the interaction was statistically significant (p < 0.05) then those 
218 results are reported. If the interaction was not significant (p ≥0.05) then the analysis was rerun 
219 without the interaction term and those results are reported.  Primary models were fit with and 
220 without covariate adjustment for sex, birth weight, and current BMI.  We adjusted for birth weight 
221 due to its potential impact on childhood development and for BMI due to evidence of an 
222 association between ECG variables and obesity (Antelmi et al. 2004). For each analysis, we used 
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223 a two-sided test with alpha = 0.05 to assess significance.  For the association of recent MeHg 
224 exposure with HRV we fit secondary models adjusting for recent n-3 and n-6 PUFA and for the 
225 participant’s activity level. Physical activity level is a main predictor of HRV (Fisher, Young, and 
226 Fadel 2015). The Global Physical Activity Questionnaire (GPAQ) was developed by WHO for 
227 physical activity surveillance. The GPAQ standardizes level of total physical activity measured in 
228 MET-minutes/week categorizing the value <600 as low sedentary activity, 600-<3000 as 
229 moderate activity, and ≥3000 as high activity. The activity measurement was based on the 
230 participants self-report of their minutes of physical activity per week using three domains (work, 
231 walking, and leisure) and was treated as a categorical variable with three levels (<600, 600-
232 <3,000, and > 3,000 minutes) following the WHO recommendation.  We adjusted for n-3 and n-6 
233 PUFA because of their reported cardiac effects (Christensen et al. 1999).  Model assumptions 
234 were checked using standard methods, including checking for constant variance, nonlinearity, 
235 and normally distributed residuals (Weisberg 2005). In some cases, there was evidence of 
236 assumption violations which necessitated a log transformation of the outcome. For variables that 
237 required a logarithmic transformation, differences from baseline values were calculated after the 
238 log transform of both variables (e.g. the outcome is the logarithm of the ratio of values, rather than 
239 the logarithm of the difference from baseline).  After transformations when required, there was no 
240 evidence of extreme outliers or highly influential observations.  We report the individual 
241 associations and corresponding betas and p values from the primary analysis.  Additionally, we 
242 applied the Bonferroni correction to account for multiple comparisons.  Since we focused on 23 
243 primary HRV parameters measured (5 in supine position, 5 in standing position, 5 in response to 
244 math test, 5 during sleep and 3 for the entire recording), we considered a p value of 0.05/23 = 
245 0.0022 as significant after this correction. 
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246 We also performed a univariate comparison of studied HRV parameters by MeHg levels 
247 categorized as 0 to <5 ppm, 5 to <10 ppm, and ≥10 ppm in prenatal and recent exposure. Median 
248 value of MeHg level in hair of US females 16-49 years of age in the NHANES 1999-2000 was 
249 0.19 µg/g with 95th percentile of 1.73 µg/g, reaching 2.75 µg/g in individuals eating fish ≥3 times 
250 in the past 30 days (McDowell et al. 2004). Prenatal assessments of women from the Seychelles 
251 high fish consumption population reported mean ± SD total hair MeHg of 6.85 ± 4.5 ppm and a 
252 median value of 5.94 ppm (Myers et al. 2003). Therefore, the cutoff of 0-5ppm was chosen as 
253 reflecting low levels of MeHg. The median total hair Hg level of women in the Faroes birth cohort 
254 study was 4.5 μg/g; 12% had levels > 10 μg/g, considered as elevated (Grandjean et al. 2004). 
255 Therefore, we proposed the above arbitrary cutoffs reflecting low, medium, and high levels of 
256 MeHg in the Seychelles fish eating populations.  
257  
258 RESULTS
259 Descriptive Analysis: Characteristics of Participants
260  There were 514 eligible participants (273 females and 241 males) who had short Holter 
261 recordings and 203 participants (117 women and 86 men) who had long Holter recordings.  Table 
262 1 shows the participants clinical characteristics, MeHg levels, and n-3 and n-6 PUFA levels 
263 compared by sex. The mean prenatal MeHg exposures were similar in males and females (6.77 
264 vs 7.06 ppm, respectively), but recent MeHg exposures at 19 years of age were significantly 
265 higher in males than females (12.16 vs. 8.67 ppm, respectively). Males were physically more 
266 active and had significantly lower BMI values than females. The n-3 and n-6 PUFA levels did not 
267 differ by sex. Correlation between prenatal Hg and recent Hg (obtained at the age of 19 years) 
268 was weak: the correlation coefficient was 0.13.
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269 As expected, time-domain SDNN and rMSSD parameters from long-term recordings and 
270 short-term supine recordings were significantly (p<0.0022) different between males and females 
271 (Supplementary Table S1). In supine resting position, males had significantly longer NN interval 
272 (lower heart rate) than females. Males also had significantly higher levels of long-term and 
273 baseline supine time-domain SDNN and rMSSD parameters, but response to standing, math test, 
274 and sleep did not significantly differ by sex. Differences in frequency-domain HRV parameters 
275 between males and females were less pronounced and did not reach p<0.0022 level.  
276 Heart Rate Variability Parameters by Categorized MeHg Exposure Levels
277 Table 2 shows a univariate comparison of studied HRV parameters by MeHg levels 
278 categorized as 0 to <5 ppm (low), 5 to <10 ppm (medium), and ≥10 ppm (high) in prenatal and 
279 recent exposure (Table 2). For prenatal MeHg exposure this comparison did not show any 
280 significant associations indicating level-related changes in HRV parameters in long term 
281 recordings, baseline supine or response to standing, math and sleep. For recent MeHg categories 
282 there were few statistically borderline associations (p value between 0.0022 and 0.05) which were 
283 driven by lower values in medium than low and high MeHg exposure: NN in response to standing 
284 and math test, LF in response to sleep, and HF at baseline, in response to math and sleeps. 
285 Among these associations the direction was inconsistent and there was no evidence of a dose 
286 response.  Since we observed sex-related differences in HRV parameters we reanalyzed 24-hour 
287 HRV data for males and females separately using the primary time domain parameters (NN, 
288 SDNN, rMSSD) and 3 additional ones (pNN50, SDANN, & SDNNIX).  No significant associations 
289 were present in these HRV parameters among subject with low, medium, and high MeHg 
290 exposure (Supplementary Table S2).          
291 Regression Analysis: Prenatal MeHg Exposure and Heart Rate Variability
13
292 The sex by prenatal exposure interaction was significant for the NN interval long recording 
293 and the NN in response to sleep (Table 3).  After adjusting for sex, birth weight, and BMI, there 
294 were two borderline significant associations at p value between 0.0022 and 0.05.  Both were in 
295 males; and one was beneficial and the other adverse. The NN interval in the long recording was 
296 predicted to increase in males by 5.5 ms per 1 ppm increase in MeHg (p=0.006). This beneficial 
297 association reflected a 0.5 beat per minute decrease in heart rate per 1 ppm increase in MeHg, 
298 or a 3.4 beat per minute decrease per IQR increase in MeHg.  The NN interval in response to 
299 sleep  decreased only in males by 10.49 ms per 1 ppm increase in MeHg (p = 0.0055), reflecting 
300 about 0.5 a beat per minute increase in heart rate, physiologically an adverse association. When 
301 the Bonferroni correction was applied, none of the associations reached statistical significance 
302 (p<0.0022). There were no other significant interactions or associations of prenatal MeHg with 
303 either the time- or frequency-domain HRV parameters computed from the long or short 
304 recordings.  
305 Regression Analysis: Recent MeHg Exposure at 19 years and Heart Rate Variability 
306 Recent MeHg exposure was associated with four outcomes in models that adjusted for 
307 sex, BMI, and birth weight (Supplementary Table S3).  Only one sex by MeHg interaction was 
308 borderline significant at p between 0.0022 and 0.05, the NN interval in response to standing (p = 
309 0.015).  That association was only in females and was adverse (p = 0.0172).  For the NN interval 
310 in response to standing, females had a 3 ms increase in the difference in the NN interval per 1 
311 ppm increase of MeHg (p = 0.017), or a 20.8 ms increase in the difference in the NN interval for 
312 an interquartile range (IQR). The associations with the two most classical time-domain 
313 parameters: SDNN baseline supine and on the long recording were not significant (p=0.600 and 
314 0.128 respectively). Similarly, the associations with rMSSD resting supine and on the long 
315 recording were not significant (p=0.197 and 0.489, respectively).  For the difference in log 
14
316 (rMSSD) in response to a math test, there was a 0.009 ms increase for each 1 ppm increase in 
317 MeHg, a beneficial response.  Stated differently, a 1 ppm increase in exposure was associated 
318 with a 1% increase in the ratio of rMSSD at baseline to the rMSSD during the math test, or an 
319 IQR increase in exposure was associated with a 6.4% increase in this ratio.  For HF in response 
320 to standing both sexes together had a 0.40% increase in difference from baseline (p=0.029), and 
321 for HF in response to the math test, they had a 0.375% increase in difference from baseline 
322 (p=0.032), indicating lower parasympathetic parameters during these tests. These associations 
323 were inconsistent in direction, of small magnitude, nonsignificant after Bonferroni correction, and 
324 of uncertain meaning.  
325 After additional adjustment for activity levels and n-3 and n-6 PUFA, recent MeHg 
326 exposure had borderline significant sex by recent MeHg interactions in two models: the NN 
327 interval in response to standing and the LF in response to the math test (Table 4).  The association 
328 between MeHg and NN interval in response to standing was borderline at p=0.0499 only in 
329 females who had on average a 2.6 ms increase per 1 ppm increase in recent MeHg. There was 
330 also a borderline (p=0.0210) association between MeHg and LF in response to the math test for 
331 males only.  Each 1 ppm increase in exposure was associated with a 0.56 ms decrease in the 
332 difference in LF (a beneficial effect).  
333 Of the six significant borderline significant associations (at P between 0.0022 and 0.05) 
334 associations with the combined sexes, three were also present in the primary analysis (the 
335 difference in rMSSD on the logarithmic scale in response to the math test and the difference in 
336 HF in response to standing and to the math test).  The association with the difference in rMSSD 
337 in response to the math test was virtually unchanged, and the associations with HF responses to 
338 standing and the math test were both slightly attenuated. The three additional outcomes with 
339 borderline significant MeHg associations were the NN interval for the long recording, the baseline 
15
340 supine NN, and the LF in response to sleep.  For the baseline supine NN, each 1 ppm increase 
341 in recent MeHg was associated with on average a decrease of 3.05 ms, an adverse association. 
342 For the LF in response to sleep, each 1 ppm increase in recent MeHg was associated with a 0.69 
343 decrease (beneficial effect).  The inconsistency of these associations and their small magnitude 
344 (milliseconds) make them challenging to interpret.  After applying the Bonferroni correction for 
345 multiplicity, there were no statistically significant MeHg associations (all p values >0.0022). 
346
347 DISCUSSION
348 We studied whether HRV parameters are associated with prenatal or recent MeHg 
349 exposure. We measured a comprehensive set of HRV parameters obtained from short-term (5 
350 minutes) and long-term (24 hours) Holter recordings in a cohort of young adults exposed to MeHg 
351 from frequent consumption of open ocean fish. Their prenatal MeHg exposures were 
352 approximately 10 times more than those present in the United States.  We focused on 23 
353 measured HRV variables and found none of them significant at prespecified after Bonferroni 
354 correction with p<0.0022. There were two borderline significant (at p between 0.0022 and 0.05) 
355 associations with prenatal and eight borderline significant associations with recent MeHg 
356 exposure in secondary models. The two prenatal associations were present only in males and 
357 were in opposite directions suggesting random variation.  The eight recent MeHg exposure 
358 significant associations were all of small magnitude, and there was no consistent pattern that 
359 would suggest they are related to exposure.  Following Bonferroni correction for multiplicity, there 
360 were no statistically significant (at p<0.0022) associations with either prenatal or recent MeHg 
361 exposure.  
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362 We observed the expected sex differences in HRV parameters that have been previously 
363 reported in the literature.  Males showed significantly higher values of HRV parameters than 
364 females (Agelink et al. 2001; Umetani et al. 1998), and the responses to standing and other 
365 conditions were as expected (Srinivasan, Sucharita, and Vaz 2002).  These findings in a large 
366 cohort provide reassurance that there was sufficient statistical power to detect meaningful 
367 associations of exposures and HRV if they were present.  The borderline significant findings were 
368 of very small magnitude without clear physiological or clinical meaning. Previously, we measured 
369 beat to beat blood pressure in 95 participants from this cohort, using the Finapres to record the 
370 baroreflex, another measure of autonomic nervous system integrity (Periard et al. 2015).  That 
371 study found no association of blood pressure variability with either prenatal or recent MeHg levels.  
372 These data do not support the hypothesis that prenatal or recent exposure to MeHg from fish 
373 consumption influences HRV parameters. 
374 The categorical analyses (Table 2 and Supplemental Table S2), although not adjusted for 
375 covariates, further corroborate the absence of associations between prenatal and recent MeHg 
376 exposure and the NN interval and other HRV parameters among the three exposure groups. If 
377 there was an association, one would expect some MeHg level-dependent changes in HRV 
378 parameters, but this categorical approach showed no trend toward any association, i.e. no 
379 decrease or increase in studied parameters across incremental levels of MeHg. At the same time, 
380 we were able to detect significant differences as we documented by detecting expected sex-
381 related differences in HRV parameters (positive control test).
382 Prenatal MeHg exposure was associated with about a 0.5 beat per minute slower heart 
383 rate in males per 1 ppm increase in MeHg.  This change does not have clinical meaning 
384 considering that exposure to MeHg in Western societies is generally less than 1 ppm.  Even in 
385 high fish-consuming societies like Japan, MeHg exposure is generally less than 2 ppm which 
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386 would be associated with a potential variation in heart rate of approximately 1 beat per minute.  
387 Neither time-domain nor frequency-domain HRV parameters were associated with prenatal MeHg 
388 levels.  Prenatal MeHg does not appear to be influencing parameters or autonomic nervous 
389 system activity reflected by HRV at the age of 19 years in this cohort.  
390 Several HRV parameters showed borderline significant associations after adjustment for 
391 birth weight, BMI, activity level, and n-3 and n-6 PUFA levels. These associations were all of small 
392 magnitude, inconsistent across parameters, and there was no indication of a dose response 
393 curve.  No associations were significant after Bonferroni adjustment.  Additionally, it seems most 
394 likely that if recent exposure to low levels of MeHg does impact the nervous system, it would be 
395 associated with prolonged cumulative dosage rather than the one month value that our measure 
396 determined.  Considering all of these factors, we do not believe these data provide support for 
397 the hypothesis that HRV parameters are associated with recent MeHg exposure.  
398 In analyses adjusted for PUFA and activity level, heart rate assessed during supine, 
399 standing, and math test periods increased with increasing MeHg levels with borderline 
400 significance.  A 3-milisecond decrease in NN interval translates to about 0.2- 0.3 beats per minute 
401 increase in heart rate, and has no clinical relevance. Similarly rMSSD and HF decreased with 
402 increasing recent MeHg during the math test and LF/HF with standing.  These changes were very 
403 small and not significant clinically or statistically after Bonferroni correction. In response to a math 
404 test, there was a 0.010 ms decrease in rMSSD per 1 ppm increase in MeHg, which despite 
405 borderline p=0.006 (after Bonferroni correction) is of no clinical or physiologic meaning.  
406 Roman and colleagues reviewed the literature on associations of prenatal and recent 
407 MeHg with cardiovascular outcomes (Roman et al. 2011). They noted that evidence of impact at 
408 dose levels of interest was lacking and that the “…specific measures of HRV in each study vary.”  
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409 However, based on the consistency of the epidemiological literature, they classified the evidence 
410 supporting the association of HRV with MeHg exposure as “strong” compared to other 
411 cardiovascular measures.  This reasoning is tenuous when one considers the known bias against 
412 publishing negative studies.  The European Food Safety Autority ((CONTAM) 2012) reviewed 
413 reports examining MeHg and HRV in 2012 with subsequent update in 2018 and the panel 
414 concluded that, although some studies suggest an autonomic effect of MeHg, the results were 
415 inconsistent among studies and the implication for health were unclear. 
416 Recently, Japanese researchers (Karita et al. 2018) reviewed 13 studies examining the 
417 association between MeHg and HRV parameters and 8 of them showed the significant 
418 association with MeHg and 5 failed to demonstrate any significant association.  Earlier studies 
419 that reported an association between prenatal MeHg exposure and HRV parameters varied from 
420 the current study in a number of ways. They were conducted in a variety of populations and 
421 measured HRV variables using different methods and recording times.  Also, some populations 
422 studied had significant exposures to other toxicants that might also influence HRV. 
423 Discussing studies supporting the MeHg and HRV associations, the Faroe Islands 
424 investigators reported a decrease in the coefficient of variation of RR (a HRV parameter similar 
425 to SDNN) and in LF and HF levels as prenatal MeHg increased (Sorensen et al. 1999; Grandjean 
426 et al. 2004).  Their studies differed in that Hg exposure was primarily from whale consumption 
427 and were thus co-exposed to polychlorinated biphenyls. In addition, the ECG recordings were 
428 short. The largest cohort studied to date evaluated 1,589 Koreans living near an industrial 
429 complex.  Participants ranged in age from 5 to 83 years with 389 below age 20 years, had mean 
430 hair Hg levels that were low (0.83 ug/gm), and had  5-minute ECG recordings obtained in sitting 
431 position, which affect results (Lim, Chung, and Paek 2010).  When categorized by decades of life, 
432 the 104 subjects below age 10 years had an 8.4% decrease in the HF parameter with each 1 ppm 
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433 increase in hair mercury concentration (95% confidence interval: 2.2-15.1). In a study of French 
434 Polynesians aged 12–17 years (Valera et al. 2011), significant differences were observed in 
435 LF/HF ratio, LF, and HF between the second (7.9–10.0 g/L) and third (11.0–26.0 g/L) tertiles of 
436 blood mercury concentration. That study reported no associations between HRV parameters and 
437 MeHg exposures in the 180 adults studied.  In the only intervention study (Yaginuma-Sakurai et 
438 al. 2010), a significant difference in LF  was observed between the experimental group (mean 
439 mercury levels of 8.76 µg/g in hair and 26.9 µg/L in blood) and control group, but one cannot 
440 exclude the effect of concomitant changes in levels of n-3 PUFA influenced these results.
441 Discussing studies with no clear evidence of the MeHg-HRV association, analysis of 
442 Faroese whaling men showed that blood mercury level was associated with increased coefficient 
443 of variation of RR intervals, and coefficient of variation of LF, but latent mercury level, estimated 
444 from mercury levels in blood, toe nail, and hair was not significantly associated with any HRV 
445 parameter (Choi et al. 2009). In Inuit adults (Valera, Dewailly, and Poirier 2008), blood mercury 
446 was significantly correlated with coefficient of variation of RR interval and LF in univariate 
447 analyses, but these associations were not significant after adjusting for confounders. In fish 
448 consumers from Long Island (Miller et al. 2018), HRV parameter in a multiple regression analysis 
449 were not significant after adjustment for serum docosahexaenoic acid and eicosapentaenoic acid 
450 levels. In the study of 203 children aged 9-11 years (Gump et al. 2017), LF, HF, and LF/HF ratio 
451 at rest and during stress were not significantly associated with blood mercury levels. 
452 As summarized above the effect of MeHg on HRV parameters does not seem consistent 
453 and remains uncertain. Some studies indicate changes in the sympathetic (LF) component, some 
454 in parasympathetic (HF, rMSSD), and some in both. Recording time and conditions varied among 
455 the studies as did MeHg assessments. Competing environmental pollutions such as persistent 
456 organic pollutants from consuming ocean mammals (Sorensen et al. 1999; Valera et al. 2011), 
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457 and underlying comorbidities such as in the Korean study (Lim, Chung, and Paek 2010), might 
458 also have influenced the findings.  If there is a causal association of prenatal or recent MeHg 
459 exposure with changes in the autonomic nervous system, one would expect consistency in the 
460 directionality of the associations for both classical time-domain and frequency-domain HRV 
461 parameters.  No study has demonstrated this.  Our study with a large cohort and a wide range of 
462 prenatal and recent MeHg exposures does not confirm the earlier reports.  
463 We want to stress than none of the studies published to date in the literature on MeHg 
464 association with HRV parameters has used 24-hour recording, the most standard approach to 
465 evaluate HRV in cardiovascular literature. The strengths of this study consist of having accurate 
466 prenatal and recent MeHg exposure measures at 19 years of age, a large cohort whose MeHg 
467 exposure is significantly higher than other reported cohorts, a comprehensive battery of HRV 
468 parameters completed under controlled conditions over a prolonged time period, blinding of 
469 clinicians to exposure, and a priori specified analysis plans.  Additionally, the analyses identified 
470 known associations of HRV parameters indicating that if MeHg did influence autonomic control of 
471 HRV the study could have detected it.  As with all epidemiological studies, there are also 
472 limitations.  Complete data were not available on all subjects, conditions during the overnight 
473 recordings were not monitored, and we were not able to complete long recordings on all 
474 participants.  Furthermore, our measure of recent exposure was limited to the month prior to 
475 evaluation.  
476 In conclusion, in a large cohort of 19 year old participants with MeHg exposures 
477 significantly above those in previous reports, we found variations in HRV parameters related to 
478 sex that have been previously reported, but found no association of them with prenatal MeHg 
479 exposure. We found some trends toward associations of recent (at the age of 19 years) MeHg 
480 exposure with heart rate and HRV parameters when subjects were challenged with math test that 
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481 could suggest that concurrent MeHg exposure might influence autonomic response, but the 
482 magnitude of these findings is so miniscule that it could not be considered meaningful from a 
483 clinical standpoint.  In addition, we are cautious with this interpretation because of the multiple 
484 comparisons and small magnitude of the associations.  We do not believe that these data support 
485 the hypothesis that either prenatal or recent MeHg exposure from consuming naturally 
486 contaminated ocean fish adversely influences heart rate variability in young adults. 
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Table 1: Characteristics of 19-year old subjects with comparison of males and females.
All     Females   Males P value
N Mean ± SD N Mean ± SD N Mean ± SD
BMI (kg/m2) 507 22.25 ± 4.83 270  22.93 ± 5.60 237 21.47 ± 3.6 0.06
Child’s Birth Weight (Kg) 514 3.18 ± 0.5 273   3.12 ± 0.48 241   3.25 ± 0.51 0.01
Prenatal MeHg (ppm) 514 6.92 ± 4.54 273  7.06  ± 4.68 241   6.77 ± 4.37 0.65
Recent MeHg (ppm) 451 10.21 ± 5.79 253   8.67 ± 4.76 198 12.16 ± 6.37 <0.01
n-3 LCPUFA (mg/ml) 482 0.05 ± 0.02 256   0.05 ± 0.02 226   0.04 ± 0.02 0.48
n-6 LCPUFA (mg/ml) 482 0.15 ± 0.04 256   0.15 ± 0.04 226   0.15 ± 0.05 0.85
Activity Level (total MET): N (%) N (%) N (%)
Sedentary (< 600) 171 (33.6%)  137 (50.6%) 34 (14.3%) <0.01
Moderate (600 - < 3,000) 139 (27.3%)  87 (32.1%) 52 (21.9%) 0.01
High (3,000+) 199 (39.1%) 47 (17.3%)  152 (63.9%)48 <0.01
Activity level: categorized from participants reports of their weekly walking, working, and recreational 
activities, in minutes estimated time per week (MET).
P values are from the nonparametric Wilcoxon rank-sum test
n-3 = sum of DHA, EPA, and ALA.  n-6 = sum of AA and LA
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Table 2. Average heart rate variability measurements by categories of prenatal and recent (at 19 years of age) MeHg (ppm) exposure^
Prenatal MeHg Recent MeHg
0-<5 ppm 
(n=211)
5-<10 ppm 
(n=184)
10+ ppm 
(n=119)
     0-<5 ppm 
  (n=63) 
   5-<10 ppm 
(n=201)
    10+ ppm 
    (n=187)
Outcome
Mean±SD Mean±SD Mean±SD
P value
mean±SD mean±SD mean±SD
P 
value*
NN (ms)
Long-term Recording 794±84 795±95 825±98 0.19 768±75 806±90 806±102 0.12
Baseline Supine 928±167 915±162 922±154 0.76 890±156 907±160 936±168 0.08
Response to Standing Δ 157±99 149±94 160±92 0.43 152±99 141±93 168±96 0.02
Response to Math Test Δ 65±72 67±80 81±87 0.28 78±84 59±71 80±87 0.04
Response to Sleep Δ -101±153 -110±146 -140±114 0.44 -112±130 -109±150 -118±142 0.98
SDNN (ms)
Long-term Recording 181±40 181±421 182±39 0.97 173±44 180±41 184±40 0.31
Baseline Supine 83±39 80±37 82±36 0.74 83±39 78±34 86±41 0.39
Response to Standing  Δ 5±33 8±32 3±27 0.73 12±32 3±27 8±37 0.36
Response to Math Test Δ 9±24 8±27 6±28 0.74 10±28 5±23 11±28 0.20
Response to Sleep Δ -11±40 -17±43 -17±38 0.64 -4±34 -12±38 -18±46 0.29
rMSSD (ms)
Long-term Recording 66±28 63±33 64±24 0.52 64±25 63±25 69±35 0.88
Baseline Supine 77±42 73±44 74±42 0.46 76±44 71±41 79±46 0.37
Response to Standing  Δ 31±32 31±35 31±32 0.70 35±38 27±29 35±35 0.13
Response to Math Test  Δ 11±27 12±30 11±34 0.49 14±35 8±24 15±36 0.25
Response to Sleep Δ -10±36 -11±40 -18±32 0.60 -8±36 -15±36 -9±41 0.44
LF
Baseline Supine 39±16 41±17 40±16 0.72 35±15 42±17 39±15 0.03
Response to Standing Δ -15±25 -15±23 -13±26 0.72 -17±24 -12±25 -17±24 0.23
Response to Math Test Δ -7±19 -4±22 -6±20 0.51 -8±19 -3±22 -8±18 0.23
Response to Sleep Δ 3±22 8±21 8±22 0.33 0±18 10±22 3±23 0.03
HF
Baseline Supine 50±19 49±20 40±16 0.72 55±18 47±19 51±19 0.01
Response to Standing Δ 29±21 26±21 -13±26 0.72 30±24 23±21 30±20 0.01
Response to Math Test Δ 7±19 7±22 -6±20 0.51 10±20 4±20 10±20 0.10
Response to Sleep Δ -4±26 -3±27 8±22 0.33 0±27 -10±27 1±24 0.02
^P = value is from 2-df nonparametric Kruskal Wallis ANOVA test
Δ = Difference between baseline values and values obtained at standing, math test, or sleeping, respectively
* Please note that significant differences were observed when comparing middle MeHg dose group with  lower and higher dose groups without dose-dependent effect.  
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Table 3. Prenatal MeHg (ppm) exposure association with heart rate variability measurements, 
adjusting for sex, birth weight and BMI
Outcome N P value for 
sex 
interaction
β P value 95% CI
NN (ms)
Long-term Recording 202 0.0230 1.883 0.1160 (-0.4710, 4.2360)
female -0.1729 0.9073 (-3.0974, 2.7516)
male 5.494 0.0058 (1.6105, 9.3775)
Baseline Supine 507 0.3050 -1.303 0.3470 (-4.0210, 1.4150)
Response to Standing Δ 497 0.2717 -0.185 0.8420 (-2.0120, 1.6410)
Response to Math Test Δ 442 0.5480 1.534 0.0620 (-0.0760, 3.1440)
Response to Sleep Δ 202 0.0120 -2.915 0.2000 (-7.3900, 1.5600)
female 1.3949 0.6203 (-4.1492, 6.9390)
male -10.4873 0.0055 (-17.8493, -3.1253)
SDNN (ms)
Long-term Recording + 200 0.1820 -0.001 0.7160 (-0.0080, 0.0050)
Baseline Supine + 507 0.4077 -0.004 0.4120 (-0.0120, 0.0050)
Response to Standing * 497 0.8190 -0.001 0.7080 (-0.0090, 0.0060)
Response to Math Test * 442 0.9039 0.000 0.9360 (-0.0070, 0.0060)
Response to Sleep * 202 0.7592 -0.003 0.7310 (-0.0180, 0.0130)
rMSSD (ms)
Long-term Recording + 202 0.5522 -0.006 0.3470 (-0.0180, 0.0060)
Baseline Supine + 499 0.2371 -0.008 0.1730 (-0.0190, 0.0030)
Response to Standing * 490 0.3928 0.002 0.6740 (-0.0070, 0.0110)
Response to Math Test * 434 0.3294 0.003 0.3760 (-0.0040, 0.0110)
Response to Sleep * 199 0.6891 -0.001 0.9150 (-0.0170, 0.0150)
LF
Baseline Supine 505 0.9939 0.07 0.6610 (-0.2440, 0.3850)
Response to Standing Δ 496 0.3730 0.037 0.8800 (-0.4390, 0.5120)
Response to Math Test Δ 441 0.7007 -0.05 0.8130 (-0.4620, 0.3630)
Response to Sleep Δ 201 0.6549 0.246 0.4730 (-0.4280, 0.9200)
HF
Baseline Supine 505 0.4400 -0.064 0.7310 (-0.4300, 0.3020)
Response to Standing Δ 496 0.3806 -0.12 0.5650 (-0.5310, 0.2910)
Response to Math Test Δ 441 0.2875 0.131 0.5230 (-0.2700, 0.5320)
Response to Sleep Δ 201 0.1498 -0.107 0.8010 (-0.9380, 0.7250)
+ = Model uses the natural logarithm of the outcome, and slopes are multiplicative effects
Δ = Difference between baseline values and values obtained at standing, math test, or sleeping respectively
* = Difference in natural logarithms of baseline values and values obtained at standing, math test, or sleeping, 
respectively
If Male*MeHg interaction is NOT significant (p > .05), mercury coefficient reported for entire sample 
If Male*MeHg interaction IS significant (p <= .05), mercury coefficient reported by sex 
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Table 4. Recent  MeHg (ppm) exposure and n-3 and n-6 PUFA status association with heart rate 
variability measurements, adjusting for birth weight, BMI, and activity level 
Outcome N P value for sex 
interaction
β P value 95% CI
NN (ms)
Long-term Recording 167 0.3404 -2.755 0.0270 (-5.191, -0.319)
Baseline Supine 418 0.0717 -3.048 0.0160 (-5.525, -0.571)
Response to Standing Δ 411 0.0185 0.167 0.8420 (-1.485, 1.82)
female 2.617 0.0499 (0.0011, 5.2323)
male -1.426 0.1847 (-3.5366, 0.6838)
Response to Math Test Δ 365 0.1291 0.578 0.4420 (-0.9, 2.056)
Response to Sleep Δ 167 0.4733 -0.095 0.9680 (-4.77, 4.581)
SDNN (ms)
Long-term Recording + 165 0.4254 -0.006 0.0950 (-0.012, 0.001)
Baseline Supine + 418 0.6280 -0.005 0.1870 (-0.013, 0.003)
Response to Standing Δ * 411 0.5215 0 0.9400 (-0.007, 0.007)
Response to Math Test Δ * 365 0.7105 0.004 0.1480 (-0.002, 0.01)
Response to Sleep Δ * 167 0.4633 -0.010 0.2050 (-0.026, 0.006)
rMSSD (ms)
Long-term Recording + 167 0.1793 -0.010 0.1300 (-0.022, 0.003)
Baseline Supine + 411 0.5038 -0.008 0.1280 (-0.018, 0.002)
Response to Standing Δ * 405 0.1855 0.004 0.3360 (-0.004, 0.012)
Response to Math Test Δ * 358 0.4383 0.010 0.0060 (0.003, 0.016)
Response to Sleep Δ * 165 0.4679 -0.007 0.4200 (-0.024, 0.01)
LF
Baseline Supine 416 0.3200 -0.128 0.3860 (-0.417, 0.161)
Response to Standing Δ 410 0.2926 -0.361 0.1060 (-0.798, 0.077)
Response to Math Test Δ 364 0.0425 -0.245 0.1910 (-0.612, 0.122)
female 0.209 0.4720 (-0.3615, 0.7791)
male -0.563 0.0210 (-1.0401, -0.0855)
Response to Sleep Δ 166 0.2318 -0.688 0.0500 (-1.377, 0.001)
HF
Baseline Supine 416 0.6151 0.226 0.1890 (-0.112, 0.564)
Response to Standing Δ 410 0.8996 0.490 0.0110 (0.114, 0.866)
Response to Math Test Δ 364 0.7939 0.544 0.0030 (0.188, 0.901)
Response to Sleep Δ 166 0.8533 0.814 0.0550 (-0.018, 1.646)
+ = Model uses the natural logarithm of the outcome and slopes assume multiplicative effects
Δ = Difference between baseline values and values obtained at standing, math test, or sleeping respectively
* = Difference in natural logarithms of baseline values and values obtained at standing, math test, or sleeping 
respectively
If Male*MeHg interaction is not significant (p > .05), mercury coefficient reported for entire sample 
If Male*MeHg interaction is significant (p <= .05), the mercury coefficient is reported by sex  
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Table S1: Heart rate variability parameters (n=23) from Holter recordings comparing males and 
females.
All      Female Male
N Mean ±  SD N Mean ± SD N Mean ± SD
P value
NN (ms)
Long-term Recording 203 802 ± 92 117 757 ± 68 86 863 ± 85 <0.0001
Baseline Supine 514  922 ± 162 273 847 ± 122 241 1007 ±161 <0.0001
Response to Standing Δ 504 155 ± 95 267 133 ± 85 237 179 ± 101 <0.0001
Response to Math Test Δ 448 69 ± 79 240 69 ± 79 208 70 ± 80 0.9731
Response to Sleep Δ 203 -113 ± 142 117 -102 ± 114 86 -128 ± 173 0.0414
SDNN (ms)
Long-term Recording 201 181 ± 40 117 166 ± 35 84 203 ± 36 <0.0001
Baseline Supine 514 82 ± 38 273 74 ± 37 241 90 ± 36 <0.0001
Response to Standing Δ 504 6 ± 32 267 8 ± 31 237 3 ± 33 0.0951
Response to Math Test Δ 448 8 ± 26 240 9 ± 24 208 6 ± 28 0.2266
Response to Sleep Δ 203 -14 ±  40 117 -11 ± 32 86 -19 ± 50 0.3927
rMSSD (ms)
Long-term Recording 203 65 ± 28 117 59  ± 25 86 72 ± 30 0.0002
Baseline Supine 506 75 ± 43 267 67 ± 42 239 83 ± 42 <0.0001
Response to Standing Δ 497 31± 33 262 30 ± 33 235 33 ± 33 0.0217
Response to Math Test Δ 440 11 ± 30 234 14 ± 28 206 8 ± 32 0.0149
Response to Sleep Δ 200 -12 ± 36 116 -13 ± 34 84 -11 ± 40 0.9733
LF
Baseline Supine 512 40 ± 16 272 38 ± 16 240 42 ± 16 0.0119
Response to Standing Δ 503 -15 ± 24 266 -13 ± 25 237 -17 ± 24 0.1223
Response to Math Test Δ 447 -6 ± 20 239 -5 ± 21 208 -6 ± 20 0.8824
Response to Sleep Δ 202 6 ± 22 117 3 ± 22 85 10 ± 21 0.0131
HF
Baseline Supine 512 49 ± 19 272 51 ± 20 240 48 ± 18 0.0774
Response to Standing Δ 503 27 ± 21 266 29 ± 22 237 25 ± 20 0.0415
Response to Math Test Δ 447 7 ±  20 239 8 ± 21 208 6 ± 19 0.0911
Response to Sleep Δ 202 -4.7 ± 27 117 -3 ± 28 85 -7 ± 25 0.2488
Δ = Difference between baseline values and values obtained at standing, math test, or sleeping, 
respectively. 
P values are from the nonparametric Wilcoxon rank-sum test
Table S2. Time-domain HRV parameters from long-term ECG recordings 
according to recent MeHg level categories at 19 years of age in males and females separately.
 
Recent 
MeHg 
Levels:
0-5 ppm 5-10 ppm 10+ppm P 
value
Males N=14 N=77 n=109
NN 899 ± 147 866 ± 121 871 ± 122 0.66
SDNN 187 ± 50 181 ± 49 183 ± 45 0.88
rMSSD 84 ± 37 77 ± 29 74 ± 37 0.31
pNN50 16.9 ± 6.7 13.8 ± 6.9 13.8 ± 6.1 0.24
SDANN 148 ± 43 153 ± 54 155 ± 48 0.90
SDNNIX 108 ± 36 93 ± 26 95 ± 27 0.19
Females n=49 n=127 n=79
NN 752 ± 91 759 ± 82 758 ± 82 0.87
SDNN 150 ± 44 144 ± 45 143 ± 41 0.71
rMSSD 60 ± 27 57 ± 29 64 ± 38 0.32
pNN50 11.2 ± 6.2 11.0 ± 6.7 11.2 ± 6.9 0.96
SDANN 126 ± 46 119 ± 42 116 ± 40 0.45
SDNNIX 75 ± 22 74 ± 23 77 ± 27 0.65
The same findings of no significant difference among three groups were observed for all 
other tested HRV parameters (data not shown - could be provided if needed). 
Table S3. Recent MeHg (ppm) exposure association with heart rate variability measurements after 
adjusting for sex, birth weight and BMI (Primary Models)
Outcome N P value for sex 
interaction
β P value 95% CI
NN (ms)
Long-term Recording 174 0.3674 -1.821 0.1110 (-4.0650, 0.4230)
Baseline Supine 446 0.0975 -1.448 0.2370 (-3.8540, 0.9570)
Response to Standing Δ 438 0.0149 0.645 0.4250 (-0.9420, 2.2330)
AC.RR:female 2.9957 0.0172 (0.5341, 5.4573)
AC.RR:male -0.9796 0.3479 (-3.0282, 1.069)
Response to Math Test Δ 391 0.0547 0.646 0.3720 (-0.7760, 2.0680)
Response to Sleep Δ 174 0.4293 0.512 0.8120 (-3.7330, 4.7570)
SDNN (ms)
Long-term Recording + 172 0.2179 -0.005 0.1280 (-0.0110, 0.0010)
Baseline Supine + 446 0.5166 -0.002 0.6000 (-0.0100, 0.0060)
Response to Standing * 438 0.4297 0.001 0.8650 (-0.0060, 0.0070)
Response to Math Test * 391 0.8776 0.005 0.1150 (-0.0010, 0.0100)
Response to Sleep * 174 0.7759 -0.002 0.8050 (-0.0170, 0.0130)
rMSSD (ms)
Long-term Recording + 174 0.1906 -0.008 0.1970 (-0.0190, 0.0040)
Baseline Supine + 438 0.4000 -0.003 0.4890 (-0.0130, 0.0060)
Response to Standing * 431 0.0783 0.005 0.2250 (-0.0030, 0.0130)
Response to Math Test * 383 0.1257 0.009 0.0070 (0.0020, 0.0160)
Response to Sleep * 171 0.9234 0.003 0.7520 (-0.0130, 0.0180)
LF
Baseline Supine 444 0.4601 -0.065 0.6390 (-0.3400, 0.2090)
Response to Standing Δ 437 0.5816 -0.323 0.1260 (-0.7360, 0.0910)
Response to Math Test Δ 390 0.0940 -0.162 0.3660 (-0.5130, 0.1900)
Response to Sleep Δ 173 0.0929 -0.58 0.0730 (-1.2140, 0.0540)
HF
Baseline Supine 444 0.7396 0.188 0.2510 (-0.1340, 0.5100)
Response to Standing Δ 437 0.9000 0.403 0.0290 (0.0420, 0.7650)
Response to Math Test Δ 390 0.9269 0.375 0.0320 (0.0330, 0.7160)
Response to Sleep Δ 173 0.5599 0.597 0.1270 (-0.1710, 1.3650)
+ = Model uses the natural logarithm of the outcome and slopes are multiplicative effects
Δ = Difference between baseline values and values obtained at standing, math test, or sleeping, respectively
* = Difference in natural logarithms of baseline values and values obtained at standing, math test, or sleeping, 
respectively. If Male*MeHg interaction is NOT significant (p > .05), mercury coefficient reported for entire sample 
If Male*MeHg interaction IS significant (p <= .05), mercury coefficient reported by sex
